Our data show that IL-8, MCP-1, and MIP-1β levels are reduced and GMCSF levels are elevated upon a high dose of rifampicin exhibiting that increased rifampicin treatment alters the chemokine and growth factor milieu in TB as well. This evidence concerns the gene CXCL8 and tuberculosis.